Back to KRYS
ACT Capital Partners, L.P. → KRYS
ACT Capital Partners, L.P. KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
1
Latest value
$14M
Q3 2026
Peak value
$14M
First seen
Q3 2026
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $14M | 42.0K | — | — |
Other funds holding KRYS
$1.2B
$1.1B
$1.1B
$960.7M
$857.3M
$814.4M
$774.3M